Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2452473 + Tadalafil in Men With Erectile Dysfunction
NCT01160289Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LY2452473 in erectile dysfunction (ED), sponsored by Eli Lilly and Company. Started Oct 2010; status: completed.
02
Drugs
LY2452473
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01160289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160289.